Skip to content
Screener

Tempus AI, Inc. TEM Return on equity

Return on equity at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-76.7%-98.4pp
NeoGenomics logo
NeoGenomicsNEO
-6.3%-2.0pp
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-540%-1,719pp
IQVIA logo
IQVIAIQV
23%+3.2pp
Guardant Health logo
Guardant HealthGH
-438.1%-1,655pp
Natera, Inc. logo
Natera, Inc.NTRA
-29%+4.1pp

Other financials

Income statement

See full
Revenue$382.5M+21.6%
Operating income-$75.9M-22.9%
Net income$5.6M+113%
EPS (diluted)$0.03+112%

Balance sheet

See full
Cash & equivalents$599.6M+219%
Total debt$83.5M+51.1%
Total equity$444.9M+43.7%
Total assets$2.4B+45.6%

Cash flow

See full
Operating cash flow-$7.5M
CapEx-$22.5M-400%
Free cash flow-$30.1M

Valuation

See full
Market cap$8.43B-12.3%
Enterprise value$7.91B-16.6%
P/S5.9×-4.2×

Profitability

See full
Operating margin-19.8%-3.3pp
Net margin-17.8%-2.4pp
FCF margin-19.5%

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio3.3×+1.8×

Where this comes from

Calculated from Tempus AI, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Tempus AI, Inc.’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 4:01 PM EDT
Accession
0001193125-26-326083

FAQ

What is Tempus AI, Inc.'s return on equity?
Tempus AI, Inc. (TEM) reported return on equity of -67.4% in Q2 2026.
How has Tempus AI, Inc.'s return on equity changed year-over-year?
Tempus AI, Inc.'s return on equity increased by 31.1% year-over-year, from -98% to -67.4%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about Tempus AI, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude